These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14814746)

  • 41. [Therapy of the prostate carcinoma by a combined administration of cortisone with estrogens].
    LINDNER A; PECHERSTORFER M
    Z Urol; 1956; 49(3):175-82. PubMed ID: 13338593
    [No Abstract]   [Full Text] [Related]  

  • 42. [The treatment of hormone-resistent prostate carcinoma].
    GLOOR HU
    Helv Chir Acta; 1962 Nov; 29():509-17. PubMed ID: 13948504
    [No Abstract]   [Full Text] [Related]  

  • 43. [Note on the modifications of bone alterations during the course of an epitheloma of the prostate treated with diethylstilboestrol].
    WOLFROMM G; COUSIN ; SORIN
    J Urol Medicale Chir; 1946-1947; 53(8-9):372-6. PubMed ID: 18918540
    [No Abstract]   [Full Text] [Related]  

  • 44. [The influence of the functional condition of the liver on the efficiency of estrogens in prostatic carcinoma].
    PYTEL A
    Acta Urol Belg; 1955 Jul; 23(3):201-8. PubMed ID: 13275340
    [No Abstract]   [Full Text] [Related]  

  • 45. [Remarkable efficacy of synthetic estrogens in secondary pulmonary cancer of prostatic origin].
    MEYER A; HINAUT G; LIOT F
    J Fr Med Chir Thorac; 1952; 6(1):60-4. PubMed ID: 14917860
    [No Abstract]   [Full Text] [Related]  

  • 46. Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids.
    BULBROOK RD; FRANKS LM; GREENWOOD FC
    Acta Endocrinol (Copenh); 1959 Aug; 31():481-99. PubMed ID: 13805840
    [No Abstract]   [Full Text] [Related]  

  • 47. Connective tissue disease and carcinoma of the prostate treated with estrogens: a preliminary report.
    SCHERBEL AL
    Cleve Clin Q; 1960 Apr; 27():49-57. PubMed ID: 14442642
    [No Abstract]   [Full Text] [Related]  

  • 48. [CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)].
    CALDERINI G; GAGLIARDI V
    Minerva Urol; 1964; 16():53-8. PubMed ID: 14158352
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthetic estrogens in treatment of atherosclerosis. A study of prostatic cancer patients.
    MEISSNER GF; MOEHRING CM
    Arch Intern Med; 1962 Oct; 110():467-71. PubMed ID: 14472267
    [No Abstract]   [Full Text] [Related]  

  • 50. [HORMONAL THERAPY OF CANCER].
    BANSI HW
    Ther Ggw; 1964 Sep; 103():1057-73. PubMed ID: 14337906
    [No Abstract]   [Full Text] [Related]  

  • 51. [COMPARATIVE HISTOMORPHOLOGIC ASPECTS OF THE TESTICLES BEFORE AND AFTER ESTROGEN THERAPY FOR PROSTATE CARCINOMA].
    SPAZIANTE G
    Minerva Urol; 1965; 17():12-7. PubMed ID: 14302866
    [No Abstract]   [Full Text] [Related]  

  • 52. Some aspects of the conservative management of prostatic cancer.
    FERGUSSON JD
    Proc R Soc Med; 1963 Feb; 56(2):81-8. PubMed ID: 13944759
    [No Abstract]   [Full Text] [Related]  

  • 53. [Principles for the conservative drug therapy treatment of prostate cancer].
    Hofmann W
    Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992
    [No Abstract]   [Full Text] [Related]  

  • 54. CONSERVATIVE TREATMENT OF PROSTATIC CANCER.
    FERGUSSON JD
    Lond Clin Med J; 1965 Jan; 6():15-24. PubMed ID: 14246721
    [No Abstract]   [Full Text] [Related]  

  • 55. [STEROID HORMONE EXCRETION OF PATIENTS WITH DISEASES OF THE PROSTATE UNDER TREATMENT WITH NATURAL AND SYNTHETIC ESTROGENS].
    ZIMMERMANN W; BUESCHER HK; TAUPITZ A; THEWALT K
    Acta Endocrinol (Copenh); 1964; 45():SUPPL90:211-25. PubMed ID: 14111328
    [No Abstract]   [Full Text] [Related]  

  • 56. [Porphyria cutanea tarda following treatment with depot estrogens in patients with prostate cancer].
    Linss G; Schmechel C
    Z Urol Nephrol; 1990 May; 83(5):229-31. PubMed ID: 2392882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Occurrence or development of gastric ulcers in the course of high-dosed synthetic estrogen treatments].
    VACHON A; ROMIER J
    Arch Mal Appar Dig Mal Nutr; 1955 Dec; 44(12):1301-5. PubMed ID: 13314765
    [No Abstract]   [Full Text] [Related]  

  • 58. [Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].
    Dunzendorfer U; Schulz H
    Z Urol Nephrol; 1982 Jul; 75(7):493-500. PubMed ID: 6183845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ALTERATIONS IN SERUM LACTIC DEHYDROGENASE AND ITS ISOZYMES IN PATIENTS WITH PROSTATIC CARCINOMA AFTER HORMONAL THERAPY.
    PROUT GR; MACALALAG EV; DENIS LJ
    Surg Forum; 1964; 15():486-8. PubMed ID: 14193459
    [No Abstract]   [Full Text] [Related]  

  • 60. [Mechanism of atrophic action of estrogens on the epithelium of the prostate].
    CHAMORRO A
    C R Seances Soc Biol Fil; 1950 Feb; 144(3-4):222-3. PubMed ID: 15420901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.